Folic Acid and the Prevention of Birth Defects: 30 Years of Opportunity and Controversies

被引:45
作者
Crider, Krista S. [1 ]
Qi, Yan Ping [1 ]
Yeung, Lorraine F. [1 ]
Mai, Cara T. [1 ]
Zauche, Lauren Head [2 ]
Wang, Arick [1 ]
Daniels, Kelicia [3 ]
Williams, Jennifer L. [1 ]
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Infant Outcomes Monitoring Res & Prevent Branch, Div Birth Defects & Infant Disorders,Neural Tube, Atlanta, GA 30333 USA
[2] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA
[3] Eagle Global Sci LLC, San Antonio, TX USA
关键词
NEURAL-TUBE DEFECTS; BLOOD FOLATE CONCENTRATIONS; ANTENATAL MICRONUTRIENT SUPPLEMENTATION; CORONARY-HEART-DISEASE; UNITED-STATES; VITAMIN-B-12; STATUS; FOOD FORTIFICATION; COGNITIVE IMPAIRMENT; FLOUR FORTIFICATION; CHILDBEARING-AGE;
D O I
10.1146/annurev-nutr-043020-091647
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
For three decades, the US Public Health Service has recommended that all persons capable of becoming pregnant consume 400 mu g/day of folic acid (FA) to prevent neural tube defects (NTDs). The neural tube forms by 28 days after conception. Fortification can be an effectiveNTD prevention strategy in populations with limited access to folic acid foods and/or supplements. This review describes the status of mandatory FA fortification among countries that fortify (n = 71) and the research describing the impact of those programs onNTDrates (up to 78% reduction), blood folate concentrations [red blood cell folate concentrations increased similar to 1.47-fold (95% CI, 1.27, 1.70) following fortification], and other health outcomes. Across settings, high-quality studies such as those with randomized exposures (e.g., randomized controlled trials, Mendelian randomization studies) are needed to elucidate interactions of FA with vitamin B-12 as well as expanded biomarker testing.
引用
收藏
页码:423 / 452
页数:30
相关论文
共 185 条
  • [1] Proportion of neural tube defects attributable to known risk factors
    Agopian, A. J.
    Tinker, Sarah C.
    Lupo, Philip J.
    Canfield, Mark A.
    Mitchell, Laura E.
    [J]. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2013, 97 (01) : 42 - 46
  • [2] Effect of folic acid fortification on the incidence of neural tube defects
    Amarin, Zouhair O.
    Obeidat, Ahmed Z.
    [J]. PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2010, 24 (04) : 349 - 351
  • [3] [Anonymous], 1996, Federal Register, V61, P8781
  • [4] [Anonymous], 1992, MMWR RECOMM REP, V41, P1
  • [5] Atta CAM, 2016, AM J PUBLIC HEALTH, V106, pE24, DOI 10.2105/AJPH.2015.302902
  • [6] Elevated ambient temperatures and risk of neural tube defects
    Auger, Nathalie
    Fraser, William D.
    Arbour, Laura
    Bilodeau-Bertrand, Marianne
    Kosatsky, Tom
    [J]. OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2017, 74 (05) : 315 - 320
  • [7] Aust N. Z., 2007, 706 FOOD STAND AUST
  • [8] Biomarkers of Nutrition for Development-Folate Review
    Bailey, Lynn B.
    Stover, Patrick J.
    McNulty, Helene
    Fenech, Michael F.
    Gregory, Jesse F., III
    Mills, James L.
    Pfeiffer, Christine M.
    Fazili, Zia
    Zhang, Mindy
    Ueland, Per M.
    Molloy, Anne M.
    Caudill, Marie A.
    Shane, Barry
    Berry, Robert J.
    Bailey, Regan L.
    Hausman, Dorothy B.
    Raghavan, Ramkripa
    Raiten, Daniel J.
    [J]. JOURNAL OF NUTRITION, 2015, 145 (07) : 1636 - 1680
  • [9] The pharmacokinetic advantage of 5-methyltetrahydrofolate for minimization of the risk for birth defects
    Bailey, Steven W.
    Ayling, June E.
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [10] Folate fortification and supplementation - Are we there yet?
    Bar-Oz, Benjamin
    Koren, Gideon
    Nguyen, Patricia
    Kapur, Bhushan M.
    [J]. REPRODUCTIVE TOXICOLOGY, 2008, 25 (04) : 408 - 412